China's Top Departments: Obstetrics & Gynecology at Sun Yat-sen Memorial Hospital

If you are facing a gynecologic cancer diagnosis such as advanced or recurrent ovarian cancer, managing a high-risk pregnancy, or seeking fertility treatment in South China, the Department of Obstetrics and Gynecology at Sun Yat-sen Memorial Hospital is one of the region's strongest destinations — based at a hospital with 190 years of history, rated A+ in the Fudan University China Hospital Rankings, and led by Prof. Song Erwei, an Academician of the Chinese Academy of Sciences.

Hospital Overview

Sun Yat-sen Memorial Hospital, Sun Yat-sen University (also known as the Second Affiliated Hospital of Sun Yat-sen University) is a large, comprehensive Grade 3A (tertiary) hospital integrating medical care, teaching, research, and preventive healthcare. It is a hospital directly affiliated with and supervised by the National Health Commission of China. Founded in 1835 (originally the "Ophthalmic Hospital" at the Thirteen Factories in Guangzhou), it is China's first Western-medicine hospital and the birthplace of Western medicine and Western medical education in China, with a history of 190 years. The great revolutionary pioneer Dr. Sun Yat-sen studied medicine and carried out revolutionary activities here under the name "Yat-sen." Its president is Prof. Song Erwei, an Academician of the Chinese Academy of Sciences.

In the Fudan University "2023 China Hospital Rankings," the hospital was rated A+, one of only four hospitals in Guangzhou to receive an A+ rating and one of the 11 Guangdong hospitals on the national top-100 list.

The hospital has 7 national key disciplines, 17 national key clinical specialties (including Gynecology), and 26 Guangdong provincial key clinical specialties (including Gynecology and Obstetrics), and holds qualifications for transplantation of four major organs (heart, lung, liver, and kidney). In 2020 it entered the world's top 100 research hospitals, and has ranked among China's top 10 in the Nature Index for four consecutive years.

The hospital has more than 3,000 authorized beds and over 5,700 staff, with more than 3.88 million outpatient and emergency visits and over 150,000 surgeries per year. Its campuses are located in Guangzhou and eastern Guangdong:

• North Campus (main campus): 107 Yanjiang West Road, Yuexiu District, Guangzhou (on the Pearl River, downtown)
• South Campus: 33 Yingfeng Road, Haizhu District, Guangzhou
• Huadu Campus: 11 Jinghu Avenue, Huadu District, Guangzhou
• Shenshan Campus (Shenshan Central Hospital): 1 Zhanqian Heng'er Road, Dongchong Town, Chengqu, Shanwei, Guangdong (designated National Regional Medical Center)
• South Campus Clinic; the Haizhu Bay Campus is under construction

Guangzhou is the transport hub of South China, easily reached via Guangzhou Baiyun International Airport and the Guangzhou–Shenzhen–Hong Kong high-speed rail (linking to Hong Kong West Kowloon). The North Campus sits in the prime downtown area by the Pearl River, near Yide Lu Station (Metro Line 6), convenient for patients from Hong Kong, Macao, Taiwan, and overseas.

Department Overview

Obstetrics and Gynecology is a core discipline of Sun Yat-sen Memorial Hospital, comprising two main divisions — Gynecology and Obstetrics (Perinatology) — together with several sub-specialties. Gynecology is a National Key Clinical Specialty, and Obstetrics (Perinatology) is a Guangdong Provincial Key Clinical Specialty.

The department has a well-developed sub-specialty structure:

• Gynecologic Oncology — surgery-based comprehensive treatment of benign and malignant gynecologic tumors
• General Gynecology — uterine fibroids, endometriosis/adenomyosis, ovarian cysts, cervical diseases, etc.
• Gynecologic Reproductive Endocrinology (Reproductive Medicine Center) — infertility, assisted reproduction, menstrual disorders, and reproductive endocrine diseases
• Perinatology (Obstetrics) — high-risk pregnancy and maternal-fetal medicine
• Family Planning and other units

The Division of Gynecologic Reproductive Endocrinology (Reproductive Medicine Center) is one of China's first reproductive endocrinology teams; it is a National Key Discipline, a Guangdong "12th Five-Year Plan" Key Medical Discipline, and a Guangdong Provincial High-Level Key Clinical Specialty, listed among Guangdong's "strongest departments." It is a doctoral and master's degree training site, a postdoctoral station, and a national GCP base. The Reproductive Medicine Center was approved for establishment in 2001 and is one of the larger reproductive medicine centers in Guangdong.

Academic Standing & Accreditations

• National Key Clinical Specialty (Gynecology)
• Guangdong Provincial Key Clinical Specialty (Obstetrics/Perinatology)
• National Key Discipline and Guangdong Provincial High-Level Key Clinical Specialty (Gynecologic Reproductive Endocrinology)
• The Gynecologic Oncology Division led the drafting of China's first clinical guideline on hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecologic tumors: in January 2024, the hospital completed China's first "Clinical Guideline on Hyperthermic Intraperitoneal Chemotherapy for Gynecologic Tumors," providing a systematic protocol for ovarian cancer treatment
• The Division of Gynecologic Reproductive Endocrinology is a doctoral and master's degree training site, a postdoctoral station, and a national GCP base
• The Division of Gynecologic Reproductive Endocrinology has achieved numerous world-first and China-first milestones, including the world's first healthy birth after early selective fetal reduction in a complex multiple pregnancy (monochorionic triplets), the world's second live birth in a patient with ovarian resistance syndrome using in vitro maturation (IVM), and the world's first use of a solid-surface vitrification carrier for human ovarian tissue cryopreservation

Core Technologies & Signature Conditions

• Surgery-based comprehensive treatment of gynecologic tumors: standardized surgery and comprehensive treatment for cervical cancer, ovarian cancer, endometrial cancer, vulvar cancer, gestational trophoblastic neoplasia, and other gynecologic malignancies; in 2024 the hospital led China's first HIPEC guideline for gynecologic tumors, particularly applicable to advanced/recurrent ovarian cancer and peritoneal disseminated tumors
• Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecologic tumors: multi-visceral resection combined with HIPEC for high-tumor-burden advanced ovarian cancer and peritoneal cancer
• Full-course management of ovarian cancer: standardized use of maintenance strategies such as PARP inhibitors to delay recurrence and improve prognosis
• Minimally invasive and fertility-sparing surgery for gynecologic tumors: laparoscopic and hysteroscopic minimally invasive surgery; fertility-sparing tumor treatment for young patients who wish to preserve fertility
• Assisted reproductive technologies: all modalities, including artificial insemination by husband (AIH), conventional in vitro fertilization-embryo transfer (IVF-ET, "first-generation IVF"), intracytoplasmic sperm injection (ICSI, "second-generation IVF"), and preimplantation genetic testing (PGT, "third-generation IVF")
• Female fertility preservation: including human ovarian tissue cryopreservation, offering fertility protection for cancer patients and older patients
• Comprehensive management of recurrent miscarriage and recurrent implantation failure
• Gynecologic endocrinology and endometriosis: standardized comprehensive diagnosis and treatment of polycystic ovary syndrome and endometriosis
• General gynecology and cervical diseases: minimally invasive treatment of uterine fibroids, ovarian cysts, etc.; stratified management of cervical diseases and cervical precancerous lesions
• High-risk pregnancy and maternal-fetal medicine (Perinatology): management of pregnancy complications/comorbidities and care of critically ill pregnant and postpartum women

Signature conditions include cervical cancer, ovarian cancer, endometrial cancer, vulvar cancer, gestational trophoblastic neoplasia (hydatidiform mole/choriocarcinoma), uterine fibroids, adenomyosis, ovarian cysts, endometriosis, polycystic ovary syndrome, infertility, recurrent miscarriage, and high-risk pregnancy.

Expert Team

Prof. Lin Zhongqiu (Lin Chiu-chiu) — Second-tier Professor, First-tier Chief Physician, and doctoral supervisor at Sun Yat-sen University; among its first batch of "Famous Physicians"; a renowned specialist in the Department of Obstetrics and Gynecology (Gynecologic Oncology Division) of Sun Yat-sen Memorial Hospital. He is an Academician of the Macao Academy of Medical Specialties and a consultant obstetrician-gynecologist at Macao Kiang Wu Hospital. He serves as Vice Chairman and Chairman of the Youth Committee of the Gynecologic Oncology Committee of the China Anti-Cancer Association, Vice Chairman of the Peritoneal Cancer Committee of the China Anti-Cancer Association, Vice Chairman of the Obstetrics and Gynecology Committee of the Integrated Medicine Branch of the Chinese Medical Doctor Association, Vice Chairman of the Reproductive Tract Diseases Committee of the China Association for the Promotion of Birth Health, Chairman of the Gynecologic Oncology Committee of the Guangdong Anti-Cancer Association, and Vice Chairman of the Guangdong Obstetrics and Gynecology Society of the Chinese Medical Association. He was Associate Chief Editor of the 7th–9th editions of the national textbook Obstetrics and Gynecology (People's Medical Publishing House) and has chief-edited more than 30 medical monographs. He has served as congress chairman of Sino-French gynecologic oncology conferences and remains active in frontier fields such as ovarian cancer maintenance therapy.

Prof. Yang Dongzi — MD, Professor, and doctoral supervisor; First-tier Chief Physician and Second-tier Professor in the Department of Obstetrics and Gynecology (Gynecologic Reproductive Endocrinology Division/Reproductive Medicine Center) of Sun Yat-sen Memorial Hospital; Academician of the Macao Academy of Medical Sciences. A nationally renowned reproductive endocrinology expert long engaged in clinical and research work in obstetrics, gynecology, and reproductive endocrinology.

Prof. Zhang Lan — Specialist in the Gynecologic Oncology Division, focused on precision stratification and individualized management of cervical precancerous lesions; in 2026 she delivered the report "Advances in the Diagnosis and Treatment of Cervical Precancerous Lesions 2026" at the annual meeting of the Uterine Body Tumor Committee of the China Anti-Cancer Association (CUCS).

Dr. Li Jing, Chief Physician — Gynecologic Oncology Division; skilled in surgery for ovarian, cervical, and endometrial cancer, and particularly in multi-visceral resection combined with HIPEC for high-tumor-burden advanced ovarian cancer and peritoneal cancer, as well as systematic comprehensive treatment for other advanced and recurrent patients.

Dr. Wang Lijuan, Chief Physician — Gynecologic Oncology Division; skilled in surgery and comprehensive treatment of benign and malignant gynecologic diseases, and particularly in the diagnosis and treatment of difficult, recurrent, and multi-drug-resistant cases of gestational trophoblastic neoplasia (e.g., hydatidiform mole).

Dr. Zhu Liqiong, Chief Physician — Specialist in Perinatology (Obstetrics), focusing on high-risk pregnancy and maternal and infant health.

Prof. Chen Hui — Specialist in reproductive medicine; formerly head of the expert panel for on-site accreditation of human assisted reproductive technology organized by the Guangdong Provincial Health Commission.

Note: The titles and academic appointments above are based on public sources; please refer to the hospital's latest official information for other specialists and administrative leaders.

Suitable Conditions / Who May Benefit (for international patients)

• Standardized surgery and comprehensive treatment for gynecologic malignancies such as cervical, ovarian, endometrial, and vulvar cancer (including advanced/recurrent and complex cases)
• Patients with high-tumor-burden advanced ovarian cancer or peritoneal cancer requiring HIPEC for gynecologic tumors
• Diagnosis and treatment of difficult and recurrent gestational trophoblastic neoplasia (hydatidiform mole, choriocarcinoma)
• Surgical and minimally invasive treatment of general gynecologic conditions such as uterine fibroids, adenomyosis, ovarian cysts, and endometriosis
• Young gynecologic cancer patients who wish to preserve fertility
• Assisted reproduction for couples with infertility (artificial insemination and first- to third-generation IVF)
• Women requiring fertility preservation (e.g., cancer patients, older women, or those with diminished ovarian reserve)
• Patients with recurrent miscarriage or recurrent implantation failure
• Patients with gynecologic endocrine conditions such as polycystic ovary syndrome and menstrual disorders
• Pregnant women with high-risk pregnancy or pregnancy complications/comorbidities
• Patients from Hong Kong, Macao, Taiwan, and overseas seeking minimally invasive surgery, precision tumor care, or assisted reproduction

Address & Contact

• North Campus (main campus): 107 Yanjiang West Road, Yuexiu District, Guangzhou
• South Campus: 33 Yingfeng Road, Haizhu District, Guangzhou
• Huadu Campus: 11 Jinghu Avenue, Huadu District, Guangzhou
• Shenshan Campus (Shenshan Central Hospital): 1 Zhanqian Heng'er Road, Dongchong Town, Chengqu, Shanwei, Guangdong
• Tel: +86 20 81332199 (main)
• Website: https://www.gzsys.org.cn

Note: This guide is compiled from the hospital's official website, the Sun Yat-sen University website, the Fudan China Hospital Rankings, public information on the Guangdong–Hong Kong–Macao Greater Bay Area "Hong Kong and Macao Medicine and Device Connect" scheme, and public media reports. It is for international readers' reference only; please confirm details with official hospital sources.

For a quick overview of the department, see the Sun Yat-sen Memorial Hospital Obstetrics & Gynecology department page.

Facing a gynecologic or maternity-care decision? Contact Medora for a free, personalized consultation — we help international patients coordinate appointments, interpretation and treatment at one of South China's leading OB/GYN programs.